"Mucormycosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection in humans and animals caused by any fungus in the order Mucorales (e.g., Absidia, Mucor, Rhizopus etc.) There are many clinical types associated with infection of the central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an opportunistic infection in patients with a chronic debilitating disease, particularly uncontrolled diabetes, or who are receiving immunosuppressive agents. (From Dorland, 28th ed)
| Descriptor ID |
D009091
|
| MeSH Number(s) |
C01.703.980.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mucormycosis".
Below are MeSH descriptors whose meaning is more specific than "Mucormycosis".
This graph shows the total number of publications written about "Mucormycosis" by people in this website by year, and whether "Mucormycosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 1 | 0 | 1 |
| 1996 | 2 | 0 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 4 | 0 | 4 |
| 2010 | 2 | 0 | 2 |
| 2011 | 8 | 0 | 8 |
| 2012 | 10 | 2 | 12 |
| 2013 | 4 | 1 | 5 |
| 2014 | 7 | 1 | 8 |
| 2015 | 2 | 2 | 4 |
| 2016 | 6 | 0 | 6 |
| 2017 | 2 | 0 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 4 | 0 | 4 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mucormycosis" by people in Profiles.
-
Skaria J, John TM, Varkey S, Kontoyiannis DP. Are Unique Regional Factors the Missing Link in India's COVID-19-Associated Mucormycosis Crisis? mBio. 2022 04 26; 13(2):e0047322.
-
Wurster S, Albert ND, Bharadwaj U, Kasembeli MM, Tarrand JJ, Daver N, Kontoyiannis DP. Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis. Front Immunol. 2022; 13:838344.
-
Thompson GR, Garcia-Diaz J, Miceli MH, Nguyen MH, Ostrosky-Zeichner L, Young JH, Fisher CE, Clark NM, Greenberg RN, Spec A, Kovanda L, Croos-Dabrera R, Kontoyiannis DP. Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study. Mycoses. 2022 Feb; 65(2):186-198.
-
Sharma DN, Welsh J, Kumar R. Can low-dose radiation therapy reduce the risk of mucormycosis in COVID-19 patients? J Cancer Res Ther. 2021 Oct-Dec; 17(6):1294-1296.
-
Foster CE, Revell PA, Campbell JR, Marquez L. Healthcare-associated Pediatric Cutaneous Mucormycosis at Texas Children's Hospital, 2012-2019. Pediatr Infect Dis J. 2021 08 01; 40(8):746-748.
-
Szarpak L, Chirico F, Pruc M, Szarpak L, Dzieciatkowski T, Rafique Z. Mucormycosis-A serious threat in the COVID-19 pandemic? J Infect. 2021 08; 83(2):237-279.
-
Wurster S, Tatara AM, Albert ND, Ibrahim AS, Heitman J, Lee SC, Shetty AC, McCracken C, Graf KT, Mikos AG, Bruno VM, Kontoyiannis DP. Tornadic Shear Stress Induces a Transient, Calcineurin-Dependent Hypervirulent Phenotype in Mucorales Molds. mBio. 2020 06 30; 11(3).
-
Fatemizadeh R, Rodman E, Demmler-Harrison GJ, Dinu D. Rhizopus Infection in a Preterm Infant: A Novel Use of Posaconazole. Pediatr Infect Dis J. 2020 04; 39(4):310-312.
-
Cornely OA, Hoenigl M, Lass-Flörl C, Chen SC, Kontoyiannis DP, Morrissey CO, Thompson GR. Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology. Mycoses. 2019 Sep; 62(9):716-729.
-
Aftandilian C, Eguiguren L, Mathew R, Messner A. Mucormycosis diagnosed during induction chemotherapy in five pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2019 09; 66(9):e27834.